| Table 1. Summary of Key Findings. | ||
| Intervention | Duration | Outcomes |
|---|---|---|
| Liraglutide 1.8mg/day | 26 weeks | Improved menstrual pattern, ↑ SHBG, ↓ free testosterone and ovarian volume |
| Liraglutide 3mg/day | 32 weeks | ↓ Free androgen index, ↑ SHBG, ↑ menstrual frequency |
| Liraglutide 1.2mg/day + Metformin 1000mg BID | 12 weeks | IVF pregnancy rate: 85.7% vs 28.6%; cumulative pregnancy rate: 69% vs 36% |
| Exenatide 10μg BID + Metformin 1000mg BID | 24 weeks | Ovulation rate: 86% vs 29%; ↓ FAI; ↑ SHBG |
| Exenatide 10 μg BID | 12 weeks | Spontaneous pregnancy rate: 43.6% vs 18.7% |
legenda: SHBG - Sex Hormane-Binding Globulin; IMF - In Vitro Fertilization BID - Bis In Die FAI - Fat Attenuation Index.